As the 6-OHDA-induced PD rat model used in initial studies [22] generally showed modest lesions (with less than 50.0% TH loss), further studies are needed to investigate the therapeutic efficacy of CDNF in late PD. This evidence concerns the gene CDNF and Parkinson disease.